Chinese Herbal Medicine in Acute INtracerebral Haemorrhage (CHAIN) Trial
Status:
Not yet recruiting
Trial end date:
2025-01-01
Target enrollment:
Participant gender:
Summary
TCM is an essential context of the ICH management in Chinese culture. Given the potential
benefits of Chinese herbal medicine FYTF-919 in reducing haematoma and bleeding after acute
ICH from fundamental research and small clinical studies, more reliable evidence is required
to guide ICH treatment using TCM. This study aims to determine the effectiveness and safety
of TCM in a larger sample of patients with moderate-severe ICH and provide evidence for TCM
clinical guidelines on ICH management. The presumed mechanism of action is in promoting the
reabsorption of the haematoma and perihematomal oedema in ICH.
Phase:
Phase 3
Details
Lead Sponsor:
Guangzhou University of Traditional Chinese Medicine